We are live on ! Find out more
BCWM

Ball & Co Wealth Management Portfolio holdings

AUM $141M
1-Year Est. Return 21.84%
This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+21.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$150M
AUM Growth
+$56.4M
Cap. Flow
+$48.8M
Cap. Flow %
32.49%
Top 10 Hldgs %
88.66%
Holding
93
New
20
Increased
33
Reduced
7
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 3.69%
2 Technology 0.51%
3 Communication Services 0.37%
4 Consumer Discretionary 0.28%
5 Consumer Staples 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMCI icon
76
Super Micro Computer
SMCI
$19B
$2K ﹤0.01%
+50
New +$2.39K
VKTX icon
77
Viking Therapeutics
VKTX
$3.88B
$2K ﹤0.01%
100
BHF icon
78
Brighthouse Financial
BHF
$3.57B
$1K ﹤0.01%
26
CMCSA icon
79
Comcast
CMCSA
$89.3B
$1K ﹤0.01%
43
+1
+2% +$34
EOG icon
80
EOG Resources
EOG
$71.4B
$1K ﹤0.01%
15
ALLO icon
81
Allogene Therapeutics
ALLO
$680M
-500
Closed
BRCC icon
82
BRC Inc
BRCC
$241M
$0 ﹤0.01%
38
CTVA icon
83
Corteva
CTVA
$51.3B
$0 ﹤0.01%
6
DD icon
84
DuPont de Nemours
DD
$19.5B
$0 ﹤0.01%
5
DOW icon
85
Dow Inc
DOW
$21.9B
$0 ﹤0.01%
8
+1
+14% +$25
EWG icon
86
iShares MSCI Germany ETF
EWG
$1.61B
-3,899
Closed -$164K
IBIT icon
87
iShares Bitcoin Trust
IBIT
$47.4B
-16,813
Closed -$1.03M
INDA icon
88
iShares MSCI India ETF
INDA
$6.6B
-2,936
Closed -$163K
PCT icon
89
PureCycle Technologies
PCT
$1.38B
$0 ﹤0.01%
39
SLV icon
90
iShares Silver Trust
SLV
$29.8B
-3,876
Closed -$127K
SPRY icon
91
ARS Pharmaceuticals
SPRY
$551M
-5,000
Closed -$87K
VTRS icon
92
Viatris
VTRS
$19B
$0 ﹤0.01%
21
WBD icon
93
Warner Bros
WBD
$66.2B
$0 ﹤0.01%
33

Similar funds

Ball & Co Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, Ball & Co Wealth Management held 93 positions worth $150M, up 60% from $93.9M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Ball & Co Wealth Management deployed $48.8M of net new capital in Q3 2025, opening 20 new positions and adding to 33 existing holdings. Its largest new stake was Vanguard Dividend Appreciation ETF: 93,258 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 3.7% of assets, down from 5.8% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares MSCI USA Min Vol Factor ETF, an estimated $13.8M trimmed.

  • Ball & Co Wealth Management's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 93,258 shares worth $20.1M.
  • Ball & Co Wealth Management added most to iShares Russell 1000 Growth ETF in Q3 2025, an estimated $13.9M increase.
  • Ball & Co Wealth Management's biggest Q3 2025 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $13.8M.
  • Ball & Co Wealth Management fully exited iShares Bitcoin Trust in Q3 2025, selling an estimated $1.03M.
  • Ball & Co Wealth Management's ten largest holdings make up 89% of its $150M portfolio in Q3 2025.
  • Ball & Co Wealth Management opened 20 new positions and closed 6 in Q3 2025.
  • Ball & Co Wealth Management's portfolio value rose 60% quarter-over-quarter to $150M.

Based on Ball & Co Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.